Sy
Board Certified Ophthalmologist for Clinical Studies
Syneos Health
Full-time
toronto, on
Bio & Pharmacology & Health
Posted:
June 08, 2026
Location:
toronto, on, Canada
Job Description
Lead clinical integrity as a Board Certified Ophthalmologist in a Senior Medical Director role. This position focuses on oversight and strategic contributions to ophthalmology studies in the US and Canada.
You will provide crucial insights and medical leadership, acting as a medical monitor while guiding study protocols and staff training. Your role will ensure patient safety and compliance with international clinical guidelines.
Key Responsibilities:
• Provide medical oversight for assigned clinical studies
• Contribute to protocol design and amendments
• Develop training for project teams in therapeutic areas
• Evaluate informed consent templates and feasibility assessments
• Offer after-hours medical support for studies
Requirements:
• Certification in Ophthalmology is required
• Comprehensive knowledge of GCP and drug development regulations
• Experience managing clinical study data and oversight...
You will provide crucial insights and medical leadership, acting as a medical monitor while guiding study protocols and staff training. Your role will ensure patient safety and compliance with international clinical guidelines.
Key Responsibilities:
• Provide medical oversight for assigned clinical studies
• Contribute to protocol design and amendments
• Develop training for project teams in therapeutic areas
• Evaluate informed consent templates and feasibility assessments
• Offer after-hours medical support for studies
Requirements:
• Certification in Ophthalmology is required
• Comprehensive knowledge of GCP and drug development regulations
• Experience managing clinical study data and oversight...
Apply for this Job
Submit your application for the Board Certified Ophthalmologist for Clinical Studies position at Syneos Health.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
toronto, Canada
Posted:
June 08, 2026
Deadline:
July 18, 2026